Unknown

Dataset Information

0

Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas.


ABSTRACT: Tumors frequently subvert major histocompatibility complex class I (MHC-I) peptide presentation to evade CD8+ T cell immunosurveillance, though how this is accomplished is not always well defined. To identify the global regulatory networks controlling antigen presentation, we employed genome-wide screening in human diffuse large B cell lymphomas (DLBCLs). This approach revealed dozens of genes that positively and negatively modulate MHC-I cell surface expression. Validated genes clustered in multiple pathways including cytokine signaling, mRNA processing, endosomal trafficking, and protein metabolism. Genes can exhibit lymphoma subtype- or tumor-specific MHC-I regulation, and a majority of primary DLBCL tumors displayed genetic alterations in multiple regulators. We established SUGT1 as a major positive regulator of both MHC-I and MHC-II cell surface expression. Further, pharmacological inhibition of two negative regulators of antigen presentation, EZH2 and thymidylate synthase, enhanced DLBCL MHC-I presentation. These and other genes represent potential targets for manipulating MHC-I immunosurveillance in cancers, infectious diseases, and autoimmunity.

SUBMITTER: Dersh D 

PROVIDER: S-EPMC7874576 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2020-11-02 | GSE160610 | GEO
2020-11-02 | GSE160609 | GEO
2020-11-02 | GSE160608 | GEO
| PRJNA673725 | ENA
| PRJNA673727 | ENA
| PRJNA673728 | ENA
| S-EPMC9837448 | biostudies-literature
| S-EPMC9355872 | biostudies-literature
| S-EPMC6706529 | biostudies-literature
| S-EPMC3873602 | biostudies-literature